使用Lung I-ACT工具支持护士改善与肺癌患者的临床试验讨论:一项混合方法试点研究
这项为期6个月的混合方法试点研究在英国七家NHS医院开展(四家干预点、三家对照点),通过问卷和访谈评估Lung I-ACT工具(患者版传单和护士版海报)的可接受性与实用性。34名护士参与问卷调查,干预点临床试验讨论频率增加,护士的意识、信心和知识提升。访谈11名护士和4名患者提炼出五个主题。
要点
- Lung I-ACT工具包含患者版传单和护士版海报,用于帮助肺癌护士启动临床试验讨论。
- 干预点护士的临床试验讨论频率增加,护士在讨论中的意识、信心和知识提升。
- 访谈归纳五个主题,涉及工具内容与形式、应用与实用性、实践变化、知识与信心及情境因素。
核心结论
- Lung I-ACT工具通过增加护士对临床试验机会的认知并帮助其组织对话,提升护士讨论试验的信心。
研究设计与样本
- 为期6个月的混合方法试点研究,在英国七家NHS医院开展,其中四家为干预点、三家为对照点。
- 通过在线问卷在基线、3个月和6个月收集护士的自我效能、知识、信心、意识和当前实践数据,并对干预点护士和患者进行在线访谈。
- 问卷数据采用描述性和推断性统计,访谈数据采用框架法进行主题分析。
主要发现
- 共招募34名护士问卷受访者。
- 问卷结果显示干预点临床试验讨论频率增加,护士的意识、信心和知识提升。
- 共访谈11名护士和4名患者,提炼出五个主题:工具内容与形式、工具在实践中的应用与实用性、感知到的实践变化、讨论临床试验的知识与信心、影响试验呈现的情境因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background Empowering nurses to discuss clinical trials with patients can increase recruitment rates. Clinical trials are essential for improving lung cancer patient outcomes; in the short term, they provide individuals access to new treatments and care regimens which, longer term, have the potential to advance clinical care. However, recruitment into lung cancer clinical trials is as low as 5%, and lung cancer nurses feel ill-equipped to signpost clinical trial opportunities to patients. This study aimed to pilot and assess the acceptability and utility of the ‘Lung I-ACT tool’: a newly developed resource comprising a patient-facing leaflet and a nurse-facing poster, designed to help lung cancer nurses initiate clinical trial discussions with patients. Methods A 6-month, mixed methods, pilot study was conducted at seven NHS hospital sites in the UK; four were intervention sites, three were control sites. Data on self-efficacy, knowledge, confidence, awareness and current practice were collected using online surveys for nurses at baseline, 3 and 6 months, and online interviews with lung cancer nurses and patients from intervention sites. Survey data were analysed using descriptive and inferential statistics, and interview data were thematically analysed via Framework Method. Results Thirty-four nurse respondents were recruited to the survey. Survey findings indicated increased frequency of clinical trial discussions at the intervention sites, and increased nurse awareness, confidence and knowledge to navigate these discussions. Eleven nurses and four patients were interviewed; these data comprised five themes regarding lung cancer nurses’ and patients’ views of the Lung I-ACT tool: (1) content and format of the tool, (2) application and utility of the tool in practice, (3) perceived changes to practice, (4) knowledge, awareness and confidence to discuss clinical trials, (5) contextual and situational factors impacting the presentation of clinical trials. Conclusion The Lung I-ACT tool improves nurses’ confidence in discussing trials with patients through increasing their awareness of clinical trial opportunities and helping them to structure conversations.
引用
- BMJ Open Respiratory Research:Supporting nurses to improve clinical trial discussions with patients with lung cancer using the Lung I-ACT tool: a mixed methods pilot study
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。